Challenges in implementing treat-to-target in rheumatoid arthritis: a perspective from Brazilian rheumatologists.
Autor: | Kakehasi AM; Universidade Federal de Minas Gerais, Avenida Alfredo Balena, 190, Belo Horizonte, Brazil. amkakehasi@gmail.com., Duarte ALBP; Universidade Federal de Pernambuco, Recife, Brazil., Brenol CV; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Domiciano DS; Universidade de São Paulo, São Paulo, Brazil., Laurindo IMM; Universidade Nove de Julho, São Paulo, Brazil., Bonfiglioli KR; Universidade de São Paulo, São Paulo, Brazil., da Mota LMH; Universidade de Brasília, Brasília, Brazil., Buch MH; NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, UK., de Almeida Macêdo E; AbbVie Farmacêutica Ltda, São Paulo, Brazil., Xavier RM; Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. |
---|---|
Jazyk: | angličtina |
Zdroj: | Advances in rheumatology (London, England) [Adv Rheumatol] 2024 Aug 26; Vol. 64 (1), pp. 63. Date of Electronic Publication: 2024 Aug 26. |
DOI: | 10.1186/s42358-024-00403-w |
Abstrakt: | Background: Patient management in rheumatoid arthritis (RA) has evolved to a "treat-to-target" (T2T) approach, which entails intensive treatment and regular follow-up with the goal of achieving low levels of disease activity or clinical remission. Even though a T2T approach is endorsed by professional organizations and yields superior outcomes, its implementation remains incomplete. EVEREST (EleVatE care in RhEumatoid arthritiS with Treat-to-target) is a quality-improvement initiative designed to improve the widespread implementation of a personalized T2T strategy and enable patients with RA to reach their full potential for remission. We describe the Brazilian results from the Global T2T Survey, first part of the EVEREST program. Methods: Between June and September 2022, we conducted an online survey targeting rheumatologists in Brazil. Our objective was to evaluate the barriers and knowledge gaps hindering the effective implementation of T2T strategies. To achieve this, we employed a set of multiple-choice questions specifically crafted to elicit responses categorized in a structured order. Results: 166 rheumatologists participated in the survey, 51% of them with more than 21 years of experience in rheumatology. Regarding the perceived challenges in the management of RA in clinical practice, the highest percentage of agreement/strong agreement among the participants was related to the contradictory results of disease activity measures (60%). In terms of the main barriers to assess the disease activity in clinical practice, the lack of adherence to treatment and contradictory assessments between patient-reported outcomes and composite measures were indicated by 75% and 59% of the participants, respectively, as a moderate/serious barrier. The most frequently knowledge and skill gaps related to the management of RA pointed out by the participants were on the difficulty to assess patients' health literacy (54% stated to have no more than intermediate knowledge on standardized methods to assess it and 43% no more than intermediate skills on determining the level of health literacy of the patients). In general, the use of tools to support the management of RA patients in clinical practice was indicated to be unusual by the participants. Self-reflection questionnaires, patient education materials and treatment consideration checklists were pointed out as the least frequently used tools (85%, 64% and 62% of the participants stated to use them never, rarely, or only sometimes, respectively). Conclusions: Our findings indicate a greater need for design, selection, and uptake of practical strategies to further improve communication between healthcare providers and patients with RA, as well as for promoting well-informed, collaborative decision-making in their care. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |